ClinicalTrials.gov
public full text
Public Domain
Topical CP-690,550 For Chronic Plaque Psoriasis
Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis#811726
- A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis#831146
- Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)#870050
- A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis#1161710
- CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)#1048072
Record · ID 825385
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive